Exclusivity Information
Crystalyx Iono Lyx R800 holds 1 exclusivity out of which 0 have expired. Its last outstanding exclusivity is set to expire in 2029. Details of Crystalyx Iono Lyx R800's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCI | May 13, 2029 |
About Crystalyx Iono Lyx R800
Crystalyx Iono Lyx R800 is a drug
owned by RIDLEY USA INC.
Crystalyx Iono Lyx R800 uses
Monensin as the active
ingredient.
Active Ingredient:
Crystalyx Iono Lyx R800 uses
Monensin as the active ingredient.
Check out other Drugs and Companies using
Monensin ingredient.